FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2113303181> ?p ?o ?g. }

• W2113303181 abstract "HomeHypertensionVol. 5, No. 2_pt_2Hemodynamic and reflex responses to acute and chronic antihypertensive therapy with the calcium entry blocker nifedipine. Free AccessAbstractPDF/EPUBAboutView PDFSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessAbstractPDF/EPUBHemodynamic and reflex responses to acute and chronic antihypertensive therapy with the calcium entry blocker nifedipine. W Kiowski, O Bertel, P Erne, P Bolli, U L Hulthén, R Ritz and F R Bühler W KiowskiW Kiowski Search for more papers by this author , O BertelO Bertel Search for more papers by this author , P ErneP Erne Search for more papers by this author , P BolliP Bolli Search for more papers by this author , U L HulthénU L Hulthén Search for more papers by this author , R RitzR Ritz Search for more papers by this author and F R BühlerF R Bühler Search for more papers by this author Originally published1 Mar 1983https://doi.org/10.1161/01.HYP.5.2_Pt_2.I70Hypertension. 1983;5 Previous Back to top Next FiguresReferencesRelatedDetailsCited By Bühler F (2014) Pathophysiology and Clinical Application of the Renin System: Early Steps Toward Personalized Medicine, American Journal of Hypertension, 10.1093/ajh/hpu114, 27:8, (996-999), Online publication date: 1-Aug-2014., Online publication date: 1-Aug-2014. Bravo E (2008) Adrenal Disorders Therapy in Nephrology & Hypertension, 10.1016/B978-141605484-9.50063-0, (691-695), . Bravo E (2007) Secondary Hypertension: Mineralocorticoid Excess States Hypertension, 10.1016/B978-1-4160-3053-9.50015-9, (106-118), . Brixius K, Gross T, Tossios P, Geissler H, Mehlhorn U, Schwinger R and Hekmat K (2005) INCREASED VASCULAR SELECTIVITY AND PROLONGED PHARMACOLOGICAL EFFICACY OF THE L-TYPE Ca2+ CHANNEL ANTAGONIST LERCANIDIPINE IN HUMAN CARDIOVASCULAR TISSUE, Clinical and Experimental Pharmacology and Physiology, 10.1111/j.1440-1681.2005.04265.x, 32:9, (708-713), Online publication date: 1-Sep-2005. Meredith P and Elliott H (2004) Dihydropyridine calcium channel blockers, Journal of Hypertension, 10.1097/00004872-200409000-00002, 22:9, (1641-1648), Online publication date: 1-Sep-2004. Bravo E (2001) Medical management of primary hyperaldosteronism, Current Hypertension Reports, 10.1007/s11906-001-0058-y, 3:5, (406-409), Online publication date: 1-Sep-2001. Murzenok P, Huang B and Leenen F (2000) Sympathoinhibition by Central and Peripheral Infusion of Nifedipine in Spontaneously Hypertensive Rats, Hypertension, 35:2, (631-636), Online publication date: 1-Feb-2000. Grossman E and Messerli F (1997) Effect of Calcium Antagonists on Plasma Norepinephrine Levels, Heart Rate, and Blood Pressure, The American Journal of Cardiology, 10.1016/S0002-9149(97)00722-4, 80:11, (1453-1458), Online publication date: 1-Dec-1997. Shimamoto H and Shimamoto Y (2009) Benidipine Counteracts Sodium-induced Alterations in Systemic and Regional Hemodynamics, Blood Pressure, 10.3109/08037059709086441, 6:1, (18-23), Online publication date: 1-Jan-1997. Shimamoto H and Shimamoto Y (1995) Lisinopril Improves Aortic Compliance and Renal Flow, Hypertension, 10.1161/01.HYP.25.3.327, 25:3, (327-334), Online publication date: 1-Mar-1995. Bravo E (1994) Primary Aldosteronism: Issues in Diagnosis and Management, Endocrinology and Metabolism Clinics of North America, 10.1016/S0889-8529(18)30097-5, 23:2, (271-283), Online publication date: 1-Jun-1994. Kiowski W (1993) Treatment of Disturbances in Blood-Pressure Regulation, Volume Homeostasis, and Microcirculation During Interventional Radiologic Procedures Interventional Radiology, 10.1007/978-3-662-01654-1_6, (49-58), . Grossman E, Messerli F, Oren S, Soria F and Schmieder R (1993) Disparate cardiovascular response to stress tests during isradipine and fosinopril therapy, The American Journal of Cardiology, 10.1016/0002-9149(93)90354-F, 72:7, (574-579), Online publication date: 1-Sep-1993. Leenen F and Holliwell D (1992) Antihypertensive effect of felodipine associated with persistent sympathetic activation and minimal regression of left ventricular hypertrophy, The American Journal of Cardiology, 10.1016/0002-9149(92)90156-S, 69:6, (639-645), Online publication date: 1-Mar-1992. Kiowski W and Linder L (1992) Reversal of endothelin-1-induced vasoconstriction by nifedipine in human resistance vessels in vivo in healthy subjects, The American Journal of Cardiology, 10.1016/0002-9149(92)90864-U, 69:12, (1063-1066), Online publication date: 1-Apr-1992. Kiowski W, Lüscher T, Linder L and Bühler F (1991) Endothelin-1-induced vasoconstriction in humans. Reversal by calcium channel blockade but not by nitrovasodilators or endothelium-derived relaxing factor., Circulation, 83:2, (469-475), Online publication date: 1-Feb-1991. Antolic G, Sega S and Kiauta T Spectral analysis of heart rate variability in treated and untreated patients with essential hypertension [1990] Computers in Cardiology, 10.1109/CIC.1990.144300, 0-8186-2225-3, (637-640) Kiowski W (1990) Kalziumantagonisten und Hypertonie beim älteren Patienten Herz- und Kreislauferkrankungen im Alter, 10.1007/978-3-642-85384-5_7, (57-61), . Forsyth D and Roberts C (2012) Nitrendipine and the humoral control of sodium homeostasis., British Journal of Clinical Pharmacology, 10.1111/j.1365-2125.1990.tb03817.x, 30:4, (585-592), Online publication date: 1-Oct-1990. Baba T, Tomiyama T, Murabayashi S and Takebe K (1990) Renal effects of nicardipine, a calcium antagonist, in hypertensive type 2 (non-insulin-dependent) diabetic patients with and without nephropathy, European Journal of Clinical Pharmacology, 10.1007/BF02336678, 38:5, (425-429), Online publication date: 1-May-1990. OTTOSSON A and KARLBERG B (1990) Nisoldipine-effects on the renin-angiotensin-aldosterone system and catecholamines. Studies in normotensive and hypertensive subjects, Journal of Internal Medicine, 10.1111/j.1365-2796.1990.tb00270.x, 228:5, (503-509), Online publication date: 1-Nov-1990. Saavedra H, Miranda H, Bustamante D, Pelissier T and Paeile C (1990) Evidence that the action of clonixin is non-dependent of ACh release, General Pharmacology: The Vascular System, 10.1016/0306-3623(90)90696-J, 21:4, (447-450), Online publication date: 1-Jan-1990. Howes L, Rowe P, Krum H and Louis W (2012) The effects of a single dose of dilevalol on [3H]-noradrenaline plasma kinetics and plasma lipoprotein cholesterol concentrations., British Journal of Clinical Pharmacology, 10.1111/j.1365-2125.1990.tb03637.x, 29:3, (281-287), Online publication date: 1-Mar-1990. Kiowski W, Erne P and Bühler F (1990) Use of nifedipine in hypertension and Raynaud's phenomenon, Cardiovascular Drugs and Therapy, 10.1007/BF02018296, 4:S5, (935-940), Online publication date: 1-Sep-1990. Kiowski W, Erne P, Linder L and Bühler F (1990) Arterial vasodilator effects of the dihydropyridine calcium antagonist amlodipine alone and in combination with verapamil in systemic hypertension, The American Journal of Cardiology, 10.1016/0002-9149(90)90536-A, 66:20, (1469-1472), Online publication date: 1-Dec-1990. Nozawa A, Kikuchi K, Nishimura M, Hasegawa T, Honma C, Komura H, Kobayakawa H, Suzuki S, Yamamoto M, Shimazaki S, Kudoh C, Satoh N and Iimura O (2009) Interrelationship Between Plasma Ionized Calcium, Plasma Nor-Adrenaline(NA) and Pressor Response to Infused NA in Patients with Essential Hypertension, Clinical and Experimental Hypertension. Part A: Theory and Practice, 10.3109/10641968909045449, 11:sup1, (419-426), Online publication date: 1-Jan-1989. Rigel D and Millard R (1989) Effects of calcium channel antagonists on carotid sinus baroreflex control of arterial pressure and heart rate in anesthetized dogs., Circulation Research, 64:2, (276-286), Online publication date: 1-Feb-1989. Oshima T, Matsuura H, Matsumoto K, Kido K, Otsuki T, Shingu T, Inoue I and Kajiyama G (1989) Role of Intracellular Free Calcium in the Hypotensive Response to Nifedipine How Should Elderly Hypertensive Patients Be Treated?, 10.1007/978-4-431-68340-7_13, (151-155), . Santoso T, Ismail D, Rahman A, Wangge M, Mansjoer H, Sugiarti T and Abdurahman N (1989) Hemodynamic and Neurohumoral Effects of Nifedipine Slow-Release Tablet in the Treatment of Hypertension Adalat® in the Asian Pacific Region, 10.1007/978-3-642-74911-7_11, (109-118), . Wilson J, Wahbha M, Martin P, Hainsworth R, Brownjohn A, Turney J, Davies J and Prentice C (1989) The effect of nisoldipine on renal function in the long-term treatment of hypertension in patients with and without renal impairment, European Journal of Clinical Pharmacology, 10.1007/BF00558120, 37:5, (437-441), . Houston M (1989) Pathophysiology, clinical aspects, and treatment of hypertensive crises, Progress in Cardiovascular Diseases, 10.1016/0033-0620(89)90022-4, 32:2, (99-148), Online publication date: 1-Sep-1989. Kiowski W, Eme P and Bühler F (2009) Effects of Calcium Antagonists on Atherogenesis, Clinical and Experimental Hypertension. Part A: Theory and Practice, 10.3109/10641968909035393, 11:5-6, (1085-1096), Online publication date: 1-Jan-1989. Lewis P, Psaila J, Davies W, Morgan R and Woodcock J (1989) Nifedipine in patients with peripheral vascular disease, European Journal of Vascular Surgery, 10.1016/S0950-821X(89)80012-X, 3:2, (159-164), Online publication date: 1-Apr-1989. Giles T and Massie B (1988) Role of calcium antagonists as initial pharmacologic monotherapy for systemic hypertension in patients over 60 years of age, The American Journal of Cardiology, 10.1016/0002-9149(88)91099-5, 61:16, (H13-H17), Online publication date: 1-Jun-1988. Walley T, Heagerty A, Woods K, Bing R, Pohl J and Barnett D (2012) Acute inotropic effects of intravenous nifedipine and its vehicle compared with saline: a double-blind study of systolic time intervals in normal subjects., British Journal of Clinical Pharmacology, 10.1111/j.1365-2125.1988.tb03290.x, 25:2, (187-193), Online publication date: 1-Feb-1988. Shepherd A (1988) Determinants of antihypertensive response to calcium antagonists in systemic hypertension, The American Journal of Cardiology, 10.1016/0002-9149(88)90039-2, 62:11, (92-96), Online publication date: 1-Oct-1988. Houston M (1988) The comparative effects of clonidine hydrochloride and nifedipine in the treatment of hypertensive crises, American Heart Journal, 10.1016/0002-8703(88)90531-5, 115:1, (152-159), Online publication date: 1-Jan-1988. Chrysant S, Chrysant C, Trus J and Hitchcock A (1988) Monotherapy of hypertension with darodipine: A new calcium-channel blocker, Clinical Cardiology, 10.1002/clc.4960110706, 11:7, (467-472), Online publication date: 1-Jul-1988. Messerli F, Oren S and Grossman E (1988) Effects of calcium channel blockers on systemic hemodynamics in hypertension, The American Journal of Medicine, 10.1016/0002-9343(88)90181-7, 84:3, (8-12), Online publication date: 1-Mar-1988. KATZMAN P, HULTHÉN U and HÖKFELT B (2009) Effects of the Calcium Antagonist Felodipine on the Sympathetic and Renin-Angiotensin-Aldosterone Systems in Essential Hypertension, Acta Medica Scandinavica, 10.1111/j.0954-6820.1988.tb15776.x, 223:2, (125-131) Schoen R, Frishman W and Shamoon H (1988) Hormonal and metabolic effects of calcium channel antagonists in man, The American Journal of Medicine, 10.1016/0002-9343(88)90272-0, 84:3, (492-504), Online publication date: 1-Mar-1988. Frishman W, Stroh J, Greenherg S, Suarez T, Karp A and Feled H (1988) Calcium Channel Blockers in Systemic Hypertension, Medical Clinics of North America, 10.1016/S0025-7125(16)30779-9, 72:2, (449-499), Online publication date: 1-Mar-1988. Romero J, Raij L, Granger J, Ruilope L and Rodicio J (1987) Multiple effects of calcium entry blockers on renal function in hypertension., Hypertension, 10:2, (140-151), Online publication date: 1-Aug-1987. Potter J and Beevers D (2013) Comparison of Nifedipine and captopril as Third-Line Agents in Hypertensive Patients Uncontrolled With Beta-Blocker and Diuretic Therapy, The Journal of Clinical Pharmacology, 10.1002/j.1552-4604.1987.tb03040.x, 27:5, (410-414), Online publication date: 6-May-1987. Cody R, Kubo S, Ryman K, Shaknovich A and Laragh J (1987) Systemic and pulmonary hemodynamic responses to nicardipine during graded ergometric exercise in patients with moderate to severe essential hypertension, Journal of the American College of Cardiology, 10.1016/S0735-1097(87)80209-7, 10:3, (647-654), Online publication date: 1-Sep-1987. Bertel O, Marx B and Conen D (1987) Effects of antihypertensive treatment on cerebral perfusion, The American Journal of Medicine, 10.1016/0002-9343(87)90208-7, 82:3, (29-36), Online publication date: 1-Mar-1987. Cody R (1987) Use of invasive ergometric exercise to assess the hemodynamic response to nicardipine, The American Journal of Cardiology, 10.1016/0002-9149(87)90209-8, 59:17, (J20-J24), Online publication date: 1-Jun-1987. Frishman W, Stroh J, Greenberg S, Suarez T, Karp A and Peled H (1987) Calcium-channel blockers in systemic hypertension, Current Problems in Cardiology, 10.1016/0146-2806(87)90020-X, 12:5, (290-346), Online publication date: 1-May-1987. Kiowski W, Erne P, Pfisterer M, Müller J, Bühler F and Burkart F (1987) Hemodynamic Effects of Nisoldipine in Patients with Severe Chronic Congestive Heart Failure Nisoldipine 1987, 10.1007/978-3-642-73010-8_51, (329-342), . Moser M (1987) Calcium entry blockers for systemic hypertension, The American Journal of Cardiology, 10.1016/0002-9149(87)90186-X, 59:2, (A115-A121), Online publication date: 1-Jan-1987. Schmieder R, Messerli F, Garavaglia G and Nunez B (1987) Cardiovascular effects of verapamil in patients with essential hypertension., Circulation, 75:5, (1030-1036), Online publication date: 1-May-1987. Walley T, Heagerty A, Woods K, Bing R, Pohl J and Barnett D (2012) Pharmacokinetics and pharmacodynamics of nifedipine infusion in normal volunteers., British Journal of Clinical Pharmacology, 10.1111/j.1365-2125.1987.tb03103.x, 23:6, (693-701), Online publication date: 1-Jun-1987. van Wezel H, Bovill J, Koolen J, Barendse G, Fiolet J and Dijkhuis J (1987) Myocardial metabolism and coronary sinus blood flow during coronary artery surgery: Effects of nitroprusside and nifedipine, American Heart Journal, 10.1016/0002-8703(87)90264-X, 113:2, (266-273), Online publication date: 1-Feb-1987. Kiowski W, Erne P, Pfisterer M, Mueller J, Buehler F and Burkart F (1987) Arterial vasodilator, systemic and coronary hemodynamic effects of nisoldipine in congestive heart failure secondary to ischemic or dilated cardiomyopathy, The American Journal of Cardiology, 10.1016/0002-9149(87)90859-9, 59:12, (1118-1125), Online publication date: 1-May-1987. Cody R, Kubo S, Covit A, Müller F, Lopez-Ovejero J and Laragh J (1986) Exercise hemodynamics and oxygen delivery in human hypertension. Response to verapamil., Hypertension, 8:1, (3-10), Online publication date: 1-Jan-1986.Imagawa J, Kusaba-Suzuki M and Satoh S (1986) Preferential inhibitory effect of nifedipine on angiotensin II-induced renal vasoconstriction., Hypertension, 8:10, (897-903), Online publication date: 1-Oct-1986. Elkayam U, Roth A, Hsueh W, Weber L, Freidenberger L and Rahimtoola S (1986) Neurohumoral consequences of vasodilator therapy with hydralazine and nifedipine in severe congestive heart failure, American Heart Journal, 10.1016/0002-8703(86)90017-7, 111:6, (1130-1138), Online publication date: 1-Jun-1986. Katzman P, Hulthen U and Hokfelt B (2012) The effect of 8 weeks treatment with the calcium antagonist felodipine on blood pressure, heart rate, working capacity, plasma renin activity, plasma angiotensin II, urinary catecholamines and aldosterone in patients with essential hypertension., British Journal of Clinical Pharmacology, 10.1111/j.1365-2125.1986.tb05227.x, 21:6, (633-640), Online publication date: 1-Jun-1986. Pacheco J, Fan F, Wright R, Corkadel L, Horwitz L and Reeves R (1986) Monotherapy of mild hypertension with nifedipine, The American Journal of Medicine, 10.1016/0002-9343(86)90790-4, 81:6, (20-24), Online publication date: 1-Dec-1986. McAllister R, Schloemer G and Hamann S (1986) Kinetics and dynamics of calcium entry antagonists in systemic hypertension, The American Journal of Cardiology, 10.1016/0002-9149(86)90800-3, 57:7, (D16-D21), Online publication date: 1-Feb-1986. Müller F, Bolli P, Erne P, Kiowski W and Bühler F (1986) Calcium antagonism—A New concept for treating essential hypertension, The American Journal of Cardiology, 10.1016/0002-9149(86)90806-4, 57:7, (D50-D53), Online publication date: 1-Feb-1986. Hulthén L (2009) Hemodynamic Effects of Calcium Channel Blockers in Essential Hypertension, Acta Pharmacologica et Toxicologica, 10.1111/j.1600-0773.1986.tb02523.x, 58:S2, (73-79) Kiowski W, Erne P, Bertel O, Bolli P and Bühler F (1986) Acute and chronic sympathetic reflex activation and antihypertensive response to nifedipine, Journal of the American College of Cardiology, 10.1016/S0735-1097(86)80503-4, 7:2, (344-348), Online publication date: 1-Feb-1986. Lam Y, Giard M and Warren J (2016) Alcium Channel Blockers and Treatment of Hypertension, Drug Intelligence & Clinical Pharmacy, 10.1177/106002808602000302, 20:3, (187-198), Online publication date: 1-Mar-1986. Halperin A and Cubeddu L (1986) The role of calcium channel blockers in the treatment of hypertension, American Heart Journal, 10.1016/0002-8703(86)90154-7, 111:2, (363-382), Online publication date: 1-Feb-1986. Houston M (1986) Treatment of hypertensive urgencies and emergencies with nifedipine, American Heart Journal, 10.1016/0002-8703(86)90647-2, 111:5, (963-969), Online publication date: 1-May-1986. Muller F, Ha H, Hotz H, Schmidlin O, Follath F and Buhler F (2012) Once a day verapamil in essential hypertension., British Journal of Clinical Pharmacology, 10.1111/j.1365-2125.1986.tb02863.x, 21:S2, (143S-147S), Online publication date: 1-Apr-1986. MÜLLER F, ERNE P, KIOWSKI W, BOLLI P, FOLLATH F and BÜHLER F (1986) ROLE OF CALCIUM ANTAGONISTS IN THE TREATMENT OF HYPERTENSION Advances in Pharmacological Research and Practice, 10.1016/B978-0-08-034190-3.50054-3, (309-318), . Frishman W, Charlap S and Michelson E (1986) Calcium channel blockers in systemic hypertension, The American Journal of Cardiology, 10.1016/0002-9149(86)90261-4, 58:1, (157-160), Online publication date: 1-Jul-1986. SAITO I, TAKESHITA E, SARUTA T, NAGANO S and SEKIHARA T (1986) EFFECT OF A CALCIUM ENTRY BLOCKER ON BLOOD PRESSURE, PLASMA RENIN ACTIVITY, ALDOSTERONE AND CATECHOLAMINES IN NORMOTENSIVE SUBJECTS, Clinical Endocrinology, 10.1111/j.1365-2265.1986.tb03286.x, 24:5, (565-570), Online publication date: 1-May-1986. Knight D, Kirby D and Vatner S (2018) Effects of a calcium channel blocker on cardiac output distribution in conscious hypertensive dogs., Hypertension, 7:3_pt_1, (380-385), Online publication date: 1-May-1985.Waeber B, Nussberger J and Brunner H (1985) Does renin determine the blood pressure response to calcium entry blockers?, Hypertension, 7:2, (223-227), Online publication date: 1-Mar-1985. Davidson R, Bursten S, Keeley P, Kenny M and Stewart D (1985) Oral nifedipine for the treatment of patients with severe hypertension, The American Journal of Medicine, 10.1016/0002-9343(85)90497-8, 79:4, (26-30), Online publication date: 1-Oct-1985. Bursztyn M, Grossman E and Rosenthel T (2009) Nifedipine as a Substitute for Converting Enzyme Inhibitors in the Treatment of Renovascular Hypertension, Clinical and Experimental Hypertension. Part A: Theory and Practice, 10.3109/10641968509073584, 7:8, (1187-1197), Online publication date: 1-Jan-1985. Wing L, Chalmers J, West M and Bune A (2009) Slow-Release Nifedipine as a Single or Additional Agent in the Treatment of Essential Hypertension—A Placebo-Controlled Crossover Study, Clinical and Experimental Hypertension. Part A: Theory and Practice, 10.3109/10641968509073583, 7:8, (1173-1185), Online publication date: 1-Jan-1985. Kiowski W, Bühler F, Fadayomi M, Erne P, Müller F, Hulthén U and Bolli P (1985) Age, race, blood pressure and renin: Predictors for antihypertensive treatment with calcium antagonists, The American Journal of Cardiology, 10.1016/0002-9149(85)90549-1, 56:16, (H81-H85), Online publication date: 1-Dec-1985. Nievelstein H, Van Essen H, Tijssen C, Smits J and Struyker Boudier H (1985) Systemic and regional hemodynamic actions of calcium entry blockers in conscious spontaneously hypertensive rats, European Journal of Pharmacology, 10.1016/0014-2999(85)90735-6, 113:2, (187-198), Online publication date: 1-Jul-1985. Wolchinsky C and Zsotér T (2012) The effect of diltiazem on noradrenaline release, British Journal of Pharmacology, 10.1111/j.1476-5381.1985.tb08873.x, 85:2, (387-393), Online publication date: 1-Jun-1985. Bertel O and Conen L (1985) Treatment of hypertensive emergencies with the calcium channel blocker nifedipine, The American Journal of Medicine, 10.1016/0002-9343(85)90498-X, 79:4, (31-35), Online publication date: 1-Oct-1985. Traube M, Hongo M, McAllister R and McCallum R (2013) Correlation of Plasma Levels of Nifedipine and Cardiovascular Effects After Sublingual Dosing in Normal Subjects, The Journal of Clinical Pharmacology, 10.1002/j.1552-4604.1985.tb02812.x, 25:2, (125-129), Online publication date: 1-Mar-1985. Bühler F, Bolli P, Kiowski W, Erne P, Lennart Hulthén U and Block L (1984) Renin Profiling to Select Anti hypertensive Baseline Drugs, The American Journal of Medicine, 10.1016/S0002-9343(84)80056-X, 77:2, (36-42), Online publication date: 1-Aug-1984. Feely J (2012) Nifedipine increases and glyceryl trinitrate decreases apparent liver blood flow in normal subjects., British Journal of Clinical Pharmacology, 10.1111/j.1365-2125.1984.tb05003.x, 17:1, (83-85), Online publication date: 1-Jan-1984. Moller F, Bolli P, Erne P, Kiowski W and Bühler F (1984) Use of Calcium Antagonists as Monotherapy in the Management of Hypertension, The American Journal of Medicine, 10.1016/S0002-9343(84)80079-0, 77:2, (11-15), Online publication date: 1-Aug-1984. Massie B, Hirsch A, Inouye I and Tubau J (1984) Calcium Channel Blockers as Anti hypertensive Agents, The American Journal of Medicine, 10.1016/S0002-9343(84)80049-2, 77:4, (135-142), Online publication date: 1-Oct-1984. Andersson O, Bengtsson C, Elmfeldt D, Haglund K, Hedner T, Seideman P, Sjoberg K, Stromgren E, Aberg H and Ostman J (2012) Short-term effects of felodipine, a new dihydropyridine, in hypertension., British Journal of Clinical Pharmacology, 10.1111/j.1365-2125.1984.tb02340.x, 17:3, (257-263), Online publication date: 1-Mar-1984. Bühler F (1983) Age and cardiovascular response adaptation. Determinants of an antihypertensive treatment concept primarily based on beta-blockers and calcium entry blockers., Hypertension, 5:5_pt_2, (III94), Online publication date: 1-Sep-1983. Levenson J, Safar M, Simon A, Boutier J and Griener L (1983) Systemic and arterial hemodynamic effects of nifedipine (20 mg) in mild-to-moderate hypertension., Hypertension, 10.1161/01.HYP.5.6_Pt_3.V57, 5:6_pt_3, Online publication date: 1-Nov-1983. Tarazi R (1983) Pathophysiology of essential hypertension, The American Journal of Medicine, 10.1016/0002-9343(83)90130-4, 75:4, (2-8), Online publication date: 1-Oct-1983. Prida X, Kubo S, Laragh J and Cody R (1983) Evaluation of calcium-mediated vasoconstriction in chronic congestive heart failure, The American Journal of Medicine, 10.1016/0002-9343(83)90410-2, 75:5, (795-800), Online publication date: 1-Nov-1983. Scriabine A and Taylor D (2000) Antihypertensives Ullmann's Encyclopedia of Industrial Chemistry, 10.1002/14356007.a04_235 March 1983Vol 5, Issue 2_pt_2 Advertisement Article InformationMetrics Copyright © 1983 by American Heart Associationhttps://doi.org/10.1161/01.HYP.5.2_Pt_2.I70PMID: 6337962 Originally publishedMarch 1, 1983 PDF download Advertisement" @default.
• W2113303181 created "2016-06-24" @default.
• W2113303181 creator A5015659467 @default.
• W2113303181 creator A5030727914 @default.
• W2113303181 creator A5050773007 @default.
• W2113303181 creator A5060621600 @default.
• W2113303181 creator A5063536836 @default.
• W2113303181 creator A5078302229 @default.
• W2113303181 creator A5090925294 @default.
• W2113303181 date "1983-03-01" @default.
• W2113303181 modified "2023-10-11" @default.
• W2113303181 title "Hemodynamic and reflex responses to acute and chronic antihypertensive therapy with the calcium entry blocker nifedipine." @default.
• W2113303181 cites W1844605916 @default.
• W2113303181 cites W1965094135 @default.
• W2113303181 cites W1968342754 @default.
• W2113303181 cites W1984370332 @default.
• W2113303181 cites W1990406860 @default.
• W2113303181 cites W1992719765 @default.
• W2113303181 cites W2014591579 @default.
• W2113303181 cites W2021656530 @default.
• W2113303181 cites W2037709046 @default.
• W2113303181 cites W2040253852 @default.
• W2113303181 cites W2055759115 @default.
• W2113303181 cites W2061265990 @default.
• W2113303181 cites W2062561387 @default.
• W2113303181 cites W2073551916 @default.
• W2113303181 cites W2079829604 @default.
• W2113303181 cites W2086036013 @default.
• W2113303181 cites W2086577738 @default.
• W2113303181 cites W2092771620 @default.
• W2113303181 cites W2092885332 @default.
• W2113303181 cites W2093495045 @default.
• W2113303181 cites W2121020585 @default.
• W2113303181 cites W2186883299 @default.
• W2113303181 cites W2311774690 @default.
• W2113303181 cites W2316073757 @default.
• W2113303181 cites W2405561334 @default.
• W2113303181 cites W2411953863 @default.
• W2113303181 cites W2587073892 @default.
• W2113303181 doi "https://doi.org/10.1161/01.hyp.5.2_pt_2.i70" @default.
• W2113303181 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/6337962" @default.
• W2113303181 hasPublicationYear "1983" @default.
• W2113303181 type Work @default.
• W2113303181 sameAs 2113303181 @default.
• W2113303181 citedByCount "114" @default.
• W2113303181 countsByYear W21133031812014 @default.
• W2113303181 crossrefType "journal-article" @default.
• W2113303181 hasAuthorship W2113303181A5015659467 @default.
• W2113303181 hasAuthorship W2113303181A5030727914 @default.
• W2113303181 hasAuthorship W2113303181A5050773007 @default.
• W2113303181 hasAuthorship W2113303181A5060621600 @default.
• W2113303181 hasAuthorship W2113303181A5063536836 @default.
• W2113303181 hasAuthorship W2113303181A5078302229 @default.
• W2113303181 hasAuthorship W2113303181A5090925294 @default.
• W2113303181 hasBestOaLocation W21133031811 @default.
• W2113303181 hasConcept C126322002 @default.
• W2113303181 hasConcept C164705383 @default.
• W2113303181 hasConcept C178853913 @default.
• W2113303181 hasConcept C2779066535 @default.
• W2113303181 hasConcept C2780356492 @default.
• W2113303181 hasConcept C42219234 @default.
• W2113303181 hasConcept C519063684 @default.
• W2113303181 hasConcept C71924100 @default.
• W2113303181 hasConcept C83974742 @default.
• W2113303181 hasConcept C84393581 @default.
• W2113303181 hasConceptScore W2113303181C126322002 @default.
• W2113303181 hasConceptScore W2113303181C164705383 @default.
• W2113303181 hasConceptScore W2113303181C178853913 @default.
• W2113303181 hasConceptScore W2113303181C2779066535 @default.
• W2113303181 hasConceptScore W2113303181C2780356492 @default.
• W2113303181 hasConceptScore W2113303181C42219234 @default.
• W2113303181 hasConceptScore W2113303181C519063684 @default.
• W2113303181 hasConceptScore W2113303181C71924100 @default.
• W2113303181 hasConceptScore W2113303181C83974742 @default.
• W2113303181 hasConceptScore W2113303181C84393581 @default.
• W2113303181 hasIssue "2_pt_2" @default.
• W2113303181 hasLocation W21133031811 @default.
• W2113303181 hasLocation W21133031812 @default.
• W2113303181 hasOpenAccess W2113303181 @default.
• W2113303181 hasPrimaryLocation W21133031811 @default.
• W2113303181 hasRelatedWork W1965165555 @default.
• W2113303181 hasRelatedWork W2001255429 @default.
• W2113303181 hasRelatedWork W2034978188 @default.
• W2113303181 hasRelatedWork W2075112733 @default.
• W2113303181 hasRelatedWork W2119867714 @default.
• W2113303181 hasRelatedWork W2138977193 @default.
• W2113303181 hasRelatedWork W2313355825 @default.
• W2113303181 hasRelatedWork W2554558112 @default.
• W2113303181 hasRelatedWork W2741030851 @default.
• W2113303181 hasRelatedWork W2041539101 @default.
• W2113303181 hasVolume "5" @default.
• W2113303181 isParatext "false" @default.
• W2113303181 isRetracted "false" @default.
• W2113303181 magId "2113303181" @default.
• W2113303181 workType "article" @default.